Swiss Nuclear Forum Launches Dedicated Nuclear Medicine Section
New body will be led by Dr Konrade von Bremen
New body will be led by Dr Konrade von Bremen
Company will use reactor concept optimised for high-yield production
Production of many medical radioisotopes takes place in research reactors, which are experiencing ageing issues
Aim is to deliver significant quantities of Pb-212 to drug innovators across Europe
New plant will produce life-saving molybdenum-99
Register free and get full access to NucNet for 14 days. No card required.
After the trial, keep a free account for a newsletter and a complimentary Plus article every two weeks. Or see our subscription plans for individuals and organisations.
See subscription options